ISRG News Alert Intuitive Surgical (ISRG) 502.77 12/12/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Intuitive Surgical (ISRG) 502.77 $ISRG

The Importance Of Return On Capital
Henry Le - Seeking Alpha - Fri Dec 12, 3:52AM CST
Not all businesses are created equal. There are many factors that determine a successful business. One of those factors is return on capital (ROC). I consider ROC to be is very important, probably the single most obvious factor to identifying...
MMM: 157.12 (-2.03), CHRW: 72.29 (-0.19), TROW: 82.00 (-2.21), MORN: 63.59 (-0.36), THI: 85.92 (-0.26), FDS: 134.64 (-2.89), ISRG: 502.77 (-3.35), TJX: 65.61 (+0.01), EXPD: 44.67 (+0.02), QCOM: 70.58 (-1.41), RAVN: 22.14 (-0.23), MSFT: 46.95 (-0.22), SHW: 247.24 (-6.97), ROST: 90.58 (-0.24), MA: 84.13 (-3.56), CL: 68.57 (-0.71), PETM: 77.67 (-0.77)

Intuitive Surgical Reports New Employee Option Grants for December 2014
GlobeNewswire - Thu Dec 11, 3:00PM CST
Intuitive Surgical, Inc. (Nasdaq:ISRG) today reported that equity awards approved by the Compensation Committee of the Board of Directors, which consists entirely of Independent Directors, were made to 35 new employees. Pursuant to NASDAQ Marketplace Rule 5635(c)(4), the equity awards were granted under the Intuitive Surgical, Inc. 2009 Commencement Incentive Plan, which the Board of Directors of Intuitive Surgical, Inc. adopted for the granting of equity awards to new employees. In accordance with NASDAQ rules, these grants were made under an equity incentive plan without shareholder approval. NASDAQ rules require a public announcement of equity awards to be made under this type of plan. 35 employees were granted a combination of Restricted Stock Units (RSUs) and Stock Options to purchase an aggregate of 9,707 shares of the Company's common stock; 6,846 of the shares granted were Stock Options and 2,861 of the shares granted were RSUs. Both the RSUs and Stock Options vest over four years. The Stock Options expire in 10 years assuming continued employment. No officers received any award under this plan. The exercise price for the Stock Options granted is $508.865 which was the closing price of Intuitive Surgical, Inc.'s common stock on the NASDAQ Global Market as such price was reported by NASDAQ on December 5, 2014. The Company's policy is to issue RSUs and Stock Option grants to new employees, where equity makes sense, on the fifth business day of every calendar month.
ISRG: 502.77 (-3.35)

31.5% Return Seen to Date on SmarTrend Intuitive Surgical Call (ISRG)
Comtex SmarTrend(R) - Wed Dec 10, 4:44PM CST
SmarTrend identified an Uptrend for Intuitive Surgical (NASDAQ:ISRG) on June 11th, 2014 at $380.75. In approximately 6 months, Intuitive Surgical has returned 31.53% as of today's recent price of $500.79.
ISRG: 502.77 (-3.35)

Brazil Laparoscopes Market Outlook to 2020: Key players covered include Olympus, KARL STORZ GmbH & Co, B. Braun Melsungen and Intuitive Surgical
M2 - Wed Dec 10, 11:29AM CST
Research and Markets (http://www.researchandmarkets.com/research/s258pv/brazil) has announced the addition of the "Brazil Laparoscopes Market Outlook to 2020" report to their offering. Our new report, "Brazil Laparoscopes Market Outlook to 2020", provides key market data on the Brazil Laparoscopes market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Video Laparoscopes (Rigid Tip Video Laparoscopes and Flexible Tip Video Laparoscopes), Robotic Surgical Systems and Rigid Tip Non-Video Laparoscopes. The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Laparoscopes market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Key Topics Covered: 1 List of Tables 2 Introduction 3 Laparoscopes Market, Brazil 4 Overview of Key Companies in Brazil, Laparoscopes Market 5 Appendix Companies Mentioned: - Olympus Corporation - KARL STORZ GmbH & Co. KG - Intuitive Surgical, Inc. - B. Braun Melsungen AG - Stryker Corporation - Richard Wolf GmbH For more information visit http://www.researchandmarkets.com/research/s258pv/brazil
ISRG: 502.77 (-3.35), SYK: 92.00 (-1.41)

3 Smart Ways to Invest in Stocks
Motley Fool Staff - Motley Fool - Mon Dec 08, 3:00PM CST
With as little as $50 you can start successfully investing in the stock market today. However, with everything from small cap stocks and bell weather blue chips to mutual funds and high growth stocks, knowing where to put your money can become...
NFLX: 334.48 (-0.15), ISRG: 502.77 (-3.35), AMZN: 307.32 (-0.04), TGT: 72.40 (-1.13), DIS: 91.49 (-0.26), PG: 89.55 (-0.86), AAPL: 109.73 (-1.89)

After Yesterday's Decline of 1.53%, Intuitive Surgical Offers Investors Better Value
Comtex SmarTrend(R) - Thu Dec 04, 4:24PM CST
Intuitive Surgical (NASDAQ:ISRG) traded in a range yesterday that spanned from a low of $509.00 to a high of $519.95. Yesterday, the shares fell 1.5%, which took the trading range below the 3-day low of $509.54 on volume of 180,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ISRG: 502.77 (-3.35)

Intuitive Surgical Set to Possibly Rebound After Yesterday's Selloff of 1.53%
Comtex SmarTrend(R) - Thu Dec 04, 4:23PM CST
Intuitive Surgical (NASDAQ:ISRG) traded in a range yesterday that spanned from a low of $509.00 to a high of $519.95. Yesterday, the shares fell 1.5%, which took the trading range below the 3-day low of $509.54 on volume of 180,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ISRG: 502.77 (-3.35)

da Vinci Lawsuits Continue to be Signed up by Law Firms Due to Recalls and Complications, Says Lawsuitsettlementnews.com
PR Newswire - Thu Dec 04, 4:00AM CST
MT Services LLC, a Lawsuit Settlement News Reporting Company which operates lawsuitsettlementnews.com, announced today a prime focus on assisting plaintiffs who have dealt with complications due to Intuitive Surgical System's da Vinci robot. It is estimated that the da Vinci machine is used in nearly 400K surgeries each year. Many patients who have undergone these types of surgeries have dealt with complications such as: lacerations to internal organs (including intestines), burns to internal organs and blood vessels, excessive bleeding, nerve damage, severe bowel injuries, punctured blood vessels or ureters, various vaginal injuries, and even death. There have been many lawsuits filed against Intuitive Surgical Inc., though at this time there is no specific number. The lawsuits have undoubtedly stemmed from reported injuries such as those listed above as well as others not listed. Intuitive Surgical Inc. reported in SEC 10-K filings that they have reserved $67MM to defend and settle some product liability claims in regards to the robotic surgery. Global settlement discussions haven't been reported yet, but according to industry experts, it is anticipated that some cases have actually settled privately. Many industry experts predict that cases with serious injuries and need for additional corrective surgeries could reach as high as $300-$500K per case.
ISRG: 502.77 (-3.35)

Intuitive Surgical Shares Up 35.2% Since SmarTrend's Buy Recommendation (ISRG)
Comtex SmarTrend(R) - Wed Dec 03, 11:04AM CST
SmarTrend identified an Uptrend for Intuitive Surgical (NASDAQ:ISRG) on June 11th, 2014 at $380.75. In approximately 6 months, Intuitive Surgical has returned 35.23% as of today's recent price of $514.89.
ISRG: 502.77 (-3.35)

EU5 Laparoscopes Market Outlook to 2020: Key players covered include Olympus, KARL STORZ GmbH & Co, B. Braun Melsungen and Intuitive Surgical
M2 - Tue Dec 02, 4:57AM CST
Research and Markets (http://www.researchandmarkets.com/research/xwf8vt/eu5_laparoscopes) has announced the addition of the "EU5 Laparoscopes Market Outlook to 2020" report to their offering. The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Laparoscopes market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases). Key Topics Covered: 1 List of Tables 2 Introduction 3 Laparoscopes Market, EU5 4 Laparoscopes Market, France 5 Laparoscopes Market, Germany 6 Laparoscopes Market, Italy 7 Laparoscopes Market, Spain 8 Laparoscopes Market, United Kingdom 9 Overview of Key Companies in EU5 Laparoscopes Market 10 Appendix Companies Mentioned: - Olympus Corporation - Intuitive Surgical, Inc. - KARL STORZ GmbH & Co. KG - Stryker Corporation - B. Braun Melsungen AG - Richard Wolf GmbH For more information visit http://www.researchandmarkets.com/research/xw...paroscopes
ISRG: 502.77 (-3.35), SYK: 92.00 (-1.41)

ModernGraham Quarterly Valuation Of Intuitive Surgical
Benjamin Clark - at Seeking Alpha - Mon Dec 01, 2:59PM CST

ISRG: 502.77 (-3.35)

U.S. Robotic Surgery Market Set to Diversify and Grow: Intuitive Surgical's 'da Vinci' Robot Revenues to Increasingly Rely On Procedures and Services
GlobeNewswire - Thu Nov 27, 9:05AM CST
via PRWEB - According to a recent report by iData Research (http://www.idataresearch.com), those companies looking to break into the surgical robotics market may find significant opportunities in other medical specialties, other than the MIS field dominated by Intuitive. These companies are expected to capture almost one-third of the U.S. surgical robotics market by 2020.
ISRG: 502.77 (-3.35)

Insider Trading Alert - RPTP, TEAR And ISRG Traded By Insiders
at The Street - Wed Nov 26, 10:59AM CST
Stocks with insider trader activity include RPTP, TEAR and ISRG
ISRG: 502.77 (-3.35), TEAR: 2.39 (+0.02), RPTP: 8.44 (+0.22)

Intuitive Surgical Up 34.7% Since SmarTrend Uptrend Call (ISRG)
Comtex SmarTrend(R) - Wed Nov 26, 9:41AM CST
SmarTrend identified an Uptrend for Intuitive Surgical (NASDAQ:ISRG) on June 11th, 2014 at $380.75. In approximately 6 months, Intuitive Surgical has returned 34.74% as of today's recent price of $513.00.
ISRG: 502.77 (-3.35)

Intuitive Surgical Rises 1.14% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Mon Nov 24, 4:44PM CST
Intuitive Surgical (NASDAQ:ISRG) traded in a range yesterday that spanned from a low of $513.80 to a high of $522.28. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $520.00 on volume of 262,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ISRG: 502.77 (-3.35)

SmarTrend Watching for Potential Pullback in Shares of Intuitive Surgical After 1.14% Gain
Comtex SmarTrend(R) - Mon Nov 24, 4:43PM CST
Intuitive Surgical (NASDAQ:ISRG) traded in a range yesterday that spanned from a low of $513.80 to a high of $522.28. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $520.00 on volume of 262,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ISRG: 502.77 (-3.35)

Russia General Surgery Market Outlook to 2020: Key players covered include Olympus, Ethicon, Covidien, B. Braun Melsungen, C.R. Bard, and KARL STORZ GmbH & Co
M2 - Fri Nov 21, 5:29AM CST
Research and Markets (http://www.researchandmarkets.com/research/frqkjt/russia_general) has announced the addition of the "Russia General Surgery Market Outlook to 2020" report to their offering. The report provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the General Surgery devices market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Key Topics Covered: 1 Overview 2 Introduction 3 General Surgery Market 4 Biopsy Devices Market 5 Hernia Repair Market 6 Aesthetic Lasers and Energy Devices Market 7 Colonoscopes Market 8 Esophagoscopes & Gastroscopes Market 9 Non-Vascular Stents Market 10 Laparoscopes Market 11 Endoscopy Visualization System Components Market 12 Resectoscopes Market 13 Surgical Generators Market 14 Bronchoscopes Market 15 Cystoscopes Market 16 Gynecological Devices Market 17 Hysteroscopes Market 18 Endoscopy Fluid Management Systems Market 19 Laryngoscopes Market 20 Endoscopic Reprocessors Market 21 Duodenoscopes Market 22 Ureteroscopes Market 23 Bariatric Surgery Devices Market 24 Sigmoidoscopes Market 25 Endoscopy Visualization Systems Market 26 Capsule Endoscopy Systems Market 27 SinuscopesMarket 28 Overview of Key Companies in Russia, Market 29 General Surgery Market Pipeline Products 30 Financial Deals Landscape Companies Mentioned: - B. Braun Melsungen AG - Boston Scientific Corporation - C. R. Bard, Inc. - CareFusion Corporation - Cook Group Incorporated - Covidien plc - Cynosure, Inc. - Fujifilm Holdings Corporation - Hologic, Inc. - Intuitive Surgical, Inc. - Johnson & Johnson - KARL STORZ GmbH & Co. KG - Olympus Corporation - PENTAX Medical Company - Richard Wolf GmbH - Solta Medical, Inc. - Stryker Corporation - Syneron Medical Ltd. For more information visit http://www.researchandmarkets.com/research/fr...ia_general
ELOS: 10.01 (-0.10), ISRG: 502.77 (-3.35), BSX: 13.00 (+0.11), JNJ: 104.43 (-2.29), CYNO: 28.70 (-0.04), HOLX: 25.85 (-0.52), SYK: 92.00 (-1.41)

Japan General Surgery Market Outlook to 2020 - Key players covered include Olympus, Ethicon, Covidien, B. Braun Melsungen, C.R. Bard, and KARL STORZ GmbH & Co
M2 - Fri Nov 21, 5:17AM CST
Research and Markets (http://www.researchandmarkets.com/research/7jqh2d/japan_general) has announced the addition of the "Japan General Surgery Market Outlook to 2020" report to their offering. The report provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the General Surgery devices market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Key Topics Covered: 1 Overview 2 Introduction 3 General Surgery Market 4 Aesthetic Lasers and Energy Devices Market 5 Bariatric Surgery Devices Market 6 Biopsy Devices Market 7 Bronchoscopes Market 8 Capsule Endoscopy Systems Market 9 Colonoscopes Market 10 Cystoscopes Market 11 Duodenoscopes Market 12 Endoscopic Reprocessors Market 13 Endoscopy Fluid Management Systems Market 14 Endoscopy Visualization System Components Market 15 Endoscopy Visualization Systems Market 16 Esophagoscopes & Gastroscopes Market 17 Gynecological Devices Market 18 Hernia Repair Market 19 Hysteroscopes Market 20 Laparoscopes Market 21 Laryngoscopes Market 22 Non-Vascular Stents Market 23 Resectoscopes Market 24 Sigmoidoscopes Market 25 Sinuscopes Market 26 Surgical Generators Market 27 Ureteroscopes Market 28 Overview of Key Companies in Japan, Market 29 General Surgery Market Pipeline Products 30 Financial Deals Landscape Companies Mentioned: - Advanced Sterilization Products Services Inc. - B. Braun Melsungen AG - Boston Scientific Corporation - C. R. Bard, Inc. - CareFusion Corporation - Cook Group Incorporated - Covidien plc - Fujifilm Holdings Corporation - Intuitive Surgical, Inc. - Johnson & Johnson - KARL STORZ GmbH & Co. KG - Olympus Corporation - PENTAX Medical Company - Stryker Corporation For more information visit http://www.researchandmarkets.com/research/7j...an_general
ISRG: 502.77 (-3.35), BSX: 13.00 (+0.11), JNJ: 104.43 (-2.29), SYK: 92.00 (-1.41)

Australia General Surgery Market Outlook to 2020: Key players covered include Olympus, Ethicon, Covidien, B. Braun Melsungen, C.R. Bard, and KARL STORZ GmbH & Co
M2 - Fri Nov 21, 5:12AM CST
Research and Markets (http://www.researchandmarkets.com/research/vnr2p3/australia_general) has announced the addition of the "Australia General Surgery Market Outlook to 2020" report to their offering. The report provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the General Surgery devices market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Key Topics Covered: 1 Overview 2 Introduction 3 General Surgery Market 4 Bariatric Surgery Devices Market 5 Laparoscopes Market 6 Hernia Repair Market 7 Aesthetic Lasers and Energy Devices Market 8 Biopsy Devices Market 9 Bronchoscopes Market 10 Non-Vascular Stents Market 11 Colonoscopes Market 12 Esophagoscopes & Gastroscopes Market 13 Surgical Generators Market 14 Endoscopy Visualization Systems Market 15 Resectoscopes Market 16 Hysteroscopes Market 17 Cystoscopes Market 18 Endoscopy Fluid Management Systems Market 19 Laryngoscopes Market 20 Capsule Endoscopy Systems Market 21 Ureteroscopes Market 22 Gynecological Devices Market 23 Endoscopic Reprocessors Market 24 Endoscopy Visualization System Components Market 25 Duodenoscopes Market 26 Sigmoidoscopes Market 27 Sinuscopes Market 28 Overview of Key Companies in Australia, General Surgery Market 29 General Surgery Market Pipeline Products 30 Financial Deals Landscape Companies Mentioned: - Covidien - Ethicon Endo-Surgery - Olympus Corporation - KARL STORZ GmbH & Co - Johnson & Johnson - Intuitive Surgical - C. R. Bard - B. Braun Melsungen - PENTAX Medical - Boston Scientific - Cook Group - Fujifilm Holdings - CareFusion - Stryker For more information visit http://www.researchandmarkets.com/research/vn...ia_general
ISRG: 502.77 (-3.35), BSX: 13.00 (+0.11), JNJ: 104.43 (-2.29), CFN: 58.86 (-0.14)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 171

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 361

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 219

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 241

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 121

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 137

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

Updated Category News Views 74

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Continue Reading
Vantrue's Black Friday Dash Cam Deals: Save up to 44%

Updated Category News Views 102

Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 161

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 169

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading

Top 5 Most Recently Viewed Articles

EXL to Announce 2024 Financial Results and Host Earnings Call

Updated Category News Views 136

EXL Announces 2024 Financial Results Release Date ExlService Holdings, Inc. (NASDAQ: EXLS), a prominent global player in the data and artificial intelligence sector, is gearing up to reveal its financial results for the fourth quarter and full year ending in December 2024. This important announcement will occur on a Tuesday afternoon, specifically on the 25th of February,...

Continue Reading
Jefferies Financial Group's Upcoming Investor Day Details

Updated Category News Views 172

Jefferies Financial Group Inc. (NYSE: JEF) rolled out its plan for the upcoming Investor Day scheduled for October 21, 2024. This event is set against the vibrant backdrop of Manhattan, making it a key date for traders and investors alike who are looking to gauge the firm’s strategic direction and operational pulse. Investor Day Insights: What Traders Should Know The...

Continue Reading
Investor Alert: Atkore Inc. Under Investigation for Misconduct

Updated Category News Views 220

Investor Alert on Atkore Inc. Bragar Eagel & Squire, P.C., a respected law firm specializing in shareholder rights, is actively investigating Atkore Inc. (NASDAQ: ATKR) on behalf of long-term stockholders. This inquiry arises in light of concerning allegations that may affect investors who hold or have held Atkore shares during a defined period. Current Investigation...

Continue Reading
Innovative Dust Dome Design Enhances Worksite Safety and Efficiency

Updated Category News Views 160

Revolutionizing Dust Management in Construction Innovators are continually seeking ways to enhance worksite safety and efficiency in the construction industry. One such inventor from Altoona has made significant strides by developing a novel dust management system known as THE DUST DOME. This invention stems from the personal experiences of a tile installer who recognized...

Continue Reading
MYR Group Inc. Reports Record Earnings in 2025

Updated Category News Views 186

MYR Group Inc. Reports Impressive Financial Gains THORNTON, Colo. — MYR Group Inc. (NASDAQ: MYRG), a leading provider of specialized electrical contracting services across North America, revealed outstanding financial results for the second quarter and first half of 2025 earlier today. The Company achieved a remarkable revenue growth of $900.3 million in the second...

Continue Reading